Skip to content

Earlier editions: 2020-112018-112026-09

DIVISION 106. PERSONAL HEALTH CARE (INCLUDING MATERNAL, CHILD, AND ADOLESCENT) 123100-125850›PART 5. HEREDITARY DISEASES/CONGENITAL DEFECTS 124975-125292.10›CHAPTER 3. California Stem Cell Research and Cures Bond Act 125290.10-125292.10›ARTICLE 2. California Stem Cell Research and Cures Bond Act of 2004 125291.10-125291.85

§ 125291.40

California Health and Safety Code · 2026-10 edition · updated 2026-10-04 · California

(a) Solely for the purpose of authorizing the issuance and sale, pursuant to the State General Obligation Bond Law, of the bonds and interim debt authorized by this article, the California Stem Cell Research and Cures Finance Committee is hereby created. For purposes of this article, the California Stem Cell Research and Cures Finance Committee is “the committee” as that term is used in the State General Obligation Bond Law. The committee consists of the Treasurer, the Controller, the Director of Finance, the Chairperson of the California Institute for Regenerative Medicine, and two other members of the Independent Citizens Oversight Committee (as created by the act) chosen by the Chairperson of the California Institute for Regenerative Medicine, or their designated representatives. The Treasurer shall serve as chairperson of the committee. A majority of the committee may act for the committee.

(b) For purposes of the State General Obligation Bond Law, the California Institute for Regenerative Medicine is designated the “board.”

(Added November 2, 2004, by initiative Proposition 71, Sec. 5.)

Get a plain-English answer with a citation back to this text.

Ask AI about this code
▸Contents — California Health and Safety Code

GoCodebook provides public access, search, citation, multilingual explanation, and practical interpretation of legally adopted building regulations. It is not a substitute for the official ICC or California code publications.